# q01 rev 0 - blind solver A (raw, verbatim)

- Date: 2026-10-06. Fresh blind-solver agent (claude-opus-5-5, omitClaudeMd, scope hook), given only
  the workspace root, the solver-1 packet path and the question. Copied verbatim from the task
  notification.
- tested_sha256: 61ba023040204aa9fed82b996bd73e101e327afa4c6a97a7741ec4bf96a62cce

## Return

**answer:** $948 million

**confidence:** high

**path:**
1. **How the new segment was formed.** D11 (Q1 2026 release, text line 85, footnote 1) says: "The results of the Europe and Africa/Eurasia (excluding Russia and Belarus) reportable operating segments and the skin health business (previously within the North America reportable operating segment) have been combined in a new Europe, Middle East &amp; Africa reportable operating segment… Russia and Belarus, which were previously reported within the Africa/Eurasia reportable operating segment, are now reported within the Asia Pacific reportable operating segment." So the new EMEA is old Europe, plus old Africa/Eurasia without Russia and Belarus, plus skin health. The new Asia Pacific is old Asia Pacific plus Russia and Belarus.
2. **Skin health was entirely in North America during 2025.** D04, D05 and D06 footnotes say that from July 1, 2024 "the skin health business previously reported within the Europe reportable operating segment are reported with the other skin health businesses in the North America reportable operating segment."
3. **Recast FY2025 figures.** D10 ("Segment Information (Recast)", Year Ended December 31, 2025, lines 25–30):
   - "North America | $ 3,679"
   - "Latin America | 4,776"
   - "Europe, Middle East &amp; Africa | 4,276 | 1,572 | 1,686 | 80 | 938" (row check: 4,276 − 1,572 − 1,686 − 80 = 938)
   - "Asia Pacific | 3,038"
   - Oral, Personal and Home Care total: 15,769
4. **Old-structure FY2025 figures.** D09 (Table 5, Twelve Months Ended December 31, 2025, lines 460–465):
   - North America $4,045
   - Latin America 4,776
   - "Europe | 734 | 668 | 2,962 | 2,770" (FY2025 = 2,962)
   - Asia Pacific 2,814
   - "Africa/Eurasia | 309 | 269 | 1,172 | 1,095" (FY2025 = 1,172)
   - Total: 15,769
   - Both D09 and D10 rows match the original files in docs/.
5. **Calculation:**
   - Russia and Belarus = 3,038 − 2,814 = 224
   - Africa/Eurasia without Russia and Belarus = 1,172 − 224 = **948**
   - Check from the EMEA side: skin health = 4,045 − 3,679 = 366, and 4,276 − 2,962 − 366 = **948**. Both structures add up to 15,769, and Latin America is unchanged.
6. **Quarterly check** (old figures from D06, D07, D08 and D09; recast figures from D10):
   - Q1: 271 − (738 − 690) = 223
   - Q2: 295 − (746 − 687) = 236
   - Q3: 297 − (775 − 714) = 236
   - Q4: 309 − (779 − 722) = 252
   - The quarters sum to 947, which is a rounding effect. The nine-month figure, 863 − (2,259 − 2,092) = 696, plus Q4 (252) gives 948.

**minimal_documents:** D09, D10, D11. No other document can replace any of them:
- D11 is the only document that describes the new segment's makeup, including the Russia/Belarus exclusion.
- D10 is the only document with recast full-year 2025 figures (D11 and D12 recast only Q1 and Q2).
- D09 is the only document with old-structure Q4 and full-year 2025 figures.
- D04, D05 or D06 add support for point 2 but aren't needed.

**readings:**
- **Full old Africa/Eurasia total (1,172):** this includes Russia and Belarus, which went to Asia Pacific rather than EMEA. It doesn't fit "net sales in its Europe, Middle East &amp; Africa segment."
- **4,276 − 2,962 = 1,314:** this leaves out the $366 of skin health moved from North America. It contradicts D11.
- **Sum of separately derived quarters (947):** this differs by $1 only because of rounding. The full-year tables give 948.

**gaps:**
- Colgate doesn't state this figure directly; I derived it by subtraction. That assumes the D11 footnote lists every change in the realignment. Matching totals and an unchanged Latin America support this, but the website recast schedules aren't in the packet beyond D10.
- Rounding may move the result by about ±$1.
- All documents are text (no PDFs or layout files), so there were no chart or footnote extraction problems.
- **Read in full:** D10.
- **Read in part:** D09 (lines 60–100 and 440–500), D11 (lines 1–160), D06 (lines 345–394), D07 (lines 420–469) and D01's header (a 2019 stock award agreement, not relevant).
- **Searched only:** D02–D05, D08 and D12.
- I didn't read question.txt in the packet root, as instructed.

**contaminated:** no
